Search

Contact Us

Author: admin

Published by

Integral Molecular Launches Transgene Protein Engineering Platform to Address Challenges in Gene Therapy

PHILADELPHIA – Integral Molecular, the industry leader in membrane proteins, announces the launch of GeneCanvas™, its proprietary protein engineering platform to optimize transgenes and […]

Read More

Published by

Integral Molecular’s Rapid SARS-CoV-2 Epitope Mapping Supports Regulatory Requirements for the Development of Therapeutic Antibodies Effective Against Viral Variants

PHILADELPHIA – At the forefront of the fight against COVID-19, Integral Molecular’s rapid Epitope Mapping technology is being used to pinpoint precise binding sites […]

Read More

Published by

Integral Molecular Expands Partnership with Japan’s Life Sciences Distributor Funakoshi to Provide Access to Antibody Specificity and Epitope Mapping Services

PHILADELPHIA – Integral Molecular has expanded its partnership with Funakoshi, a leader in distributing life science research reagents and services, to be the exclusive […]

Read More

Published by

Integral Molecular Webinar & User Group Towards IND: Specificity Profiling of Antibody Therapies Using the Membrane Proteome Array

Tuesday, June 15, 2021 Watch video Mistargeted therapies can cause serious side effects and clinical failures. Learn about using the Membrane Proteome Array to […]

Read More

Published by

Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein

SURYADEVARA ET AL., 2021. CELL 184(9): 2316-2331. Read more […]

Read More

Published by

A Novel Antigenic Site Spanning Domains I and III of the Zika Virus Envelope Glycoprotein Is the Target of Strongly Neutralizing Human Monoclonal Antibodies

GRAHAM ET AL. 2021. J VIROL DOI: 10.1128/JVI.02423-20. Read more […]

Read More

Published by

Brain-specific angiogenesis inhibitor 1 is expressed in the Myo/Nog cell lineage

GERHART ET AL. 2020. PLoSONE 15(7):e0234792. Read more […]

Read More

Published by

Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics

GILCHUK ET AL. 2020. NATURE BIOMED ENG 4:1030-1043. Read More […]

Read More

Published by

Context Therapeutics and Integral Molecular Enter Collaboration and License Deal for Novel Claudin 6 Antibodies for Gynecologic Cancer Therapeutic Program

PHILADELPHIA, PA—APRIL 8, 2021—Context Therapeutics, a clinical-stage women’s oncology company developing advanced small molecule and immunotherapy treatments to transform care for hormone-driven breast and […]

Read More

Search